menu
    • menu

    Company profile for hC Bioscience

    NEW Drugs in Dev: 1
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    hC Bioscience is dedicated to improving the lives of patients with the development of first-in-class tRNA-based therapeutics targeting protein dysfunction. hC Bioscience’s innovative approach to precision protein editing has the potential to treat genetically-defined conditions which account for 10-15% of all human diseases. As the building blocks and machinery of life, proteins are made from long chains of specific amino ac...
    hC Bioscience is dedicated to improving the lives of patients with the development of first-in-class tRNA-based therapeutics targeting protein dysfunction. hC Bioscience’s innovative approach to precision protein editing has the potential to treat genetically-defined conditions which account for 10-15% of all human diseases. As the building blocks and machinery of life, proteins are made from long chains of specific amino acids coded by DNA.Our team is addressing these diseases directly by creating first-in-class tRNA-based therapies that correct the proteins caused by many forms of DNA coding errors.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    hC BioscienceUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1 Broadway, Cambridge, MA 02142
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://hcbioscience.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    HC Bioscience Names Simon Tsang As Chief Business Officer
    HC Bioscience Names Simon Tsang As Chief Business Officer

    09 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240909601243/en

    BUSINESSWIRE
    09 Sep 2024
    Share Share
    Hc Bio Dmd Program Update: Trna Protein Editing In Vivo Data
    Hc Bio Dmd Program Update: Trna Protein Editing In Vivo Data

    24 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240524311149/en

    BUSINESSWIRE
    24 May 2024
    Share Share
    hC Bioscience: Preclinical Data Presentation at ASGCT
    hC Bioscience: Preclinical Data Presentation at ASGCT

    08 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240508662614/en

    BUSINESSWIRE
    08 May 2024
    Share Share
    hC Bioscience Announces Hemophilia Program, Positive Preclinical Data
    hC Bioscience Announces Hemophilia Program, Positive Preclinical Data

    23 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240423476417/en

    BUSINESSWIRE
    23 Apr 2024
    Share Share
    hC Bioscience Expands Leadership and Research & Development Teams
    hC Bioscience Expands Leadership and Research & Development Teams

    06 Sep 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/09/06/2510624/0/en/hC-Bioscience-Expands-Leadership-and-Research-Development-Teams.html

    GLOBENEWSWIRE
    06 Sep 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search